Radiation Oncology

Print Page Print   EmailEmail   Bookmark Page Bookmark   RSS Feeds RSS

 

Roger W. Byhardt, MD

 

Roger W. Byhardt, MD, FACR
Professor of Radiation Oncology

Department of Radiation Oncology
8701 Watertown Plank Road
Milwaukee, WI 53226
(414) 384-2000, x 2589 (Roberta Sahagian, secretary)

  ___________________________________
   Additional Information (curriculum vitae)
 ___________________________________

Patient Care Emphases

  • General Radiation Oncology
  • Head and Neck Cancer
  • Lung Cancer

Clinical Practice Locations

  • Zablocki VA Medical Center: (414) 384-2000, ext. 42585
  • Senator Joseph Andrea Cancer Center, Kenosha, at St. Catherine's Campus of United Healthcare Systems: (262) 577-8206

Research Interests

  • Chemoradiation for lung cancer
  • Radiation dose strategies in lung cancer
  • Chemoradiation for locally advanced head and neck cancer
  • Influence of comorbidities on treatment outcomes for lung cancer
  • Role of prophylactic cranial irradiation in non-small cell and small cell lung cancer
  • Stereotactic radioablation of early stage non-small cell lung cancer
  • Management of respiratory motion in treating small conformal fields in early
    stage lung cancer 

Education

  • Doctor of Medicine,  Medical College of Wisconsin, Milwaukee, WI (1968).

Training

  • Board Certified American Board of Radiology (1973).
  • Residency Radiation Oncology, St. Joseph Hospital, Denver, CO (1969-1972).
  • Internship Radiation Oncology, St. Joseph Hospital, Denver, CO (1968-1969).

Representative Publications

  • Byhardt, R. Toxicities in RTOG Combined Modality Trials for Inoperable Non-Small Cell Lung Cancer.  ONCOLOGY, 10 Suppl (5): 116-120, 1999.
  • Movsas, B., Scott, C., Sause, W., Byhardt, R., Komaki, R., Cox, J., Johnson, D., Lawton, C., Dar, R., Wasserman, T., Roach, M., Lee, J., Andras, E.  The Benefit of Treatment Intensification is Age and Histology-Dependent in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC):  A Quality-Adjusted Survival Analysis of Radiation Therapy Oncology Group (RTOG) Chemoradiation Studies.  INT J RADIAT ONCOL BIOL PHYS 45 (5): 1143-9, 1999.
  • Russell, A., Harris, J., Rosenberg, P., Sause, W., Fisher, B., Hoffman, J., Kraybill, W., Byhardt, R. Anal Sphincter Conservation for Patients with Adenocarcinoma of the Distal Rectum: Long-Term Results of RTOG 89-02.  INT J RADIAT ONCOL BIOL PHYS 46 (2): 313-322, 2000.
  • Sause, W., Kolesar, P., Taylor, S., Johnson, D., Livingston, R., Komaki, R., Emami, E., Curran, W., Byhardt, R., and Fisher, B.: Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer:  Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588.  CHEST 117 (2): 358-364, 2000.
  • Trotti, A., Byhardt, R., Stetz, J., Gwede, C., Corn B., Fu, K., Gunderson, L., McCormick, B., Morrisintegral, M., Rich, T., Shipley, W., Curran, W.  Common Toxicity Criteria: Version 2.0. an Improved Reference for Grading the Acute Effects of Cancer Treatment:  Impact on Radiotherapy. INT J RADIAT ONCOL BIOL PHYS 47 (1): 13-47, 2000.
  • Byhardt, R.   American College of Radiology Expert Panel on Radiation Oncology – Lung Work Group.  American College of ACR Appropriateness Criteria TM 2000.  RADIOLOGY 2000; 215 (Suppl), 1347-1375.
  • Ko, B., Sause, W., Byhardt, R., Curran, W., Fuller, D., Graham, M., Komaki, R., Weisenburger, T., Kaiser, L., Leibel, S., Brown, R.  Staging of Non-Small Cell Lung Carcinoma.  American College of Radiology.  ACR Appropriateness Criteria.  RADIOLOGY 2000 Jun; 215 Suppl:  1281-94.
  • Weisenburger, T., Graham, M., Sause W., Byhardt, R., Curran, W., Fuller, D., Ko, B., Komaki, R., Kaiser, L., Leibel, S.  Postoperative Radiotherapy in Non-Small Cell Lung Cancer.  American College of Radiology.  ACR Appropriateness Criteria.  RADIOLOGY 2000 Jun; 215 Suppl: 1295-318.
  • Komaki, R., Sause, W., Byhardt, R., Curran, W., Fuller, D., Graham, M., Ko, B., Weisenburger, T., Kaiser, L., Leibel, S., Choi, N.  Non-Small Cell Lung Cancer, Nonsurgical, Aggressive Therapy.  American College of Radiology.  ACR Appropriateness Criteria.  RADIOLOGY 2000 Jun; 215 Suppl:  1319-30.
  • Byhardt, R., Sause, W., Curran, W., Fuller, D., Graham, M., Ko, B., Komaki, R., Weisenburger, T., Kaiser, L., Leibel, S., Choi, N.  Neoadjuvant Therapy for Marginally Resectable (Clinical N2), Non-Small Cell Lung Cancer.  American College of Radiology.  ACR Appropriateness Criteria.  RADIOLOGY 2000 Jun; 215 Suppl: 1331-45.
  • Graham, M., Byhardt, R., Sause, W., Curran, W., Fuller, D., Ko, B., Komaki, R., Weisenburger, T., Kaiser, L., Leibel, S.  Non-aggressive, Non-surgical Treatment of Inoperable Non-Small Cell Lung Cancer (NSCLC).  American College of Radiology.  ACR Appropriateness Criteria.  RADIOLOGY 2000 Jun; 215 Suppl; 1347-62.
  • Sause, W., Byhardt, W., Curran, W., Fuller, D., Graham, M., Ko, B., Komaki, R., Weisenburger, T., Kaiser, L., Leibel, S., Brown, R.  Follow-up of Non-Small Cell Lung Cancer.  American College of Radiology.  ACR Appropriateness Criteria.  RADIOLOGY 2000 Jun; 215 Suppl:  1363-72.
  • Werner-Wasik, M., Scott, C., Cox, J., Sause, W., Byhardt, W., Asbell, S., Russell, A., Komaki, R., Lee, J.  Recursive Partitioning Analysis of 1999 Radiation Therapy Oncology Group (RTOG) Patients With Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC):  Identification of Five Groups With Different Survival.  INT J RADIAT ONCOL BIOL PHYS, 48 (5): 1475-1482. 2000.
  • Byhardt, R., Scott, C.  A Palliative Accelerated Irradiation Regimen for Advanced Non-Small Cell Lung Cancer vs, Conventionally Fractionated 60 Gy:  Results of a Randomized Equivalence Study:  Regarding Nestle et al.  INT J RADIAT ONCOL BIOL PHYS.  2000; 48:95-103.
  • Hammond, M., Ang, K., Byhardt, R., Campbell, B., Chapman, J., Eisenberg, B., Greven, K., Harris, J., Hoffman, J., Lange, C., McCormick, B., Mehta, M., Sandler, H., Trotti, A., Willet, C., Wolfson, A., Furness, A., Jensen, T., Grignon, D., Okunieff, P.  Radiation Therapy Oncology Group.  Research  Plan 2002-2006.  Tumor Utilization Committee.  INT J RADIAT ONCOL BIOL PHYS. 2001; 51(3 Suppl 2): 103-9.
  • Komaki, R., Chasen, M., Travis, W., Putnam, J., Fossella, F., Byhardt, R., Ro, J.  Oncodiagnosis Panel:  1999.  Cancer of the Lung:  Oncodiagnosis.  RADIOGRAPHICS. 2001 Nov-Dec; 21 (6); 1573-96.
  • Tester, W., Caplan, R., Heaney, J., Venner, P., Whittington, R., Byhardt, R., True, L., and Shipley, W.:  Neoadjuvant Combined Modality Program With Selective Organ Preservation for Invasive Bladder Cancer:  Results of Radiation Therapy Oncology Group Phase II Trial 88-02.  J Clin Oncol:  Classic Papers & Current Comments, 6 (2): 379-387, 2001.
  • Firat, S., Bousamra, M., Gore, E., Byhardt, R.  Comorbidity and KPS are Independent Prognostic Factors in Stage I Non-Small Cell Lung Cancer.  INT J RADIAT ONCOL BIOL PHYS. 2002 Mar 15;52 (4): 1047-57.
  • Firat, S., Byhardt, R., Gore, E.  Comorbidity and Karnofksy  Performance Score are Independent Prognostic Factors in Stage III Non-Small Cell Lung Cancer:  an Institutional Analysis of Patients Treated on Four RTOG Studies.  INT J RADIAT ONCOL BIOL PHYS.  2002 Oct 1;54 (2): 357.
  • Johnston, D., Byhardt, R., Ettinger, D., Scott, C.  Phase III Study Comparing Chemotherapy and Radiotherapy with Preoperative Chemotherapy and Surgical Resection in Patients with Non-Small Cell Lung Cancer with Spread to Mediastinal Lymph Nodes (N2); Final Report of RTOG 89-01.  INT J RADIAT ONCOL BIOL PHYS. 2002 Oct 1;54 (2): 365.
webmaster@mcw.edu
© 2007 Medical College of Wisconsin
Page Updated 12/11/2007